Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/10646
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Çetin, Ebru Nevin | - |
dc.contributor.author | Demirtaş, Önder | - |
dc.contributor.author | Özbakış, N.C. | - |
dc.contributor.author | Pekel, Gökhan | - |
dc.date.accessioned | 2019-08-16T13:32:12Z | |
dc.date.available | 2019-08-16T13:32:12Z | |
dc.date.issued | 2018 | - |
dc.identifier.issn | 0721-832X | - |
dc.identifier.uri | https://hdl.handle.net/11499/10646 | - |
dc.identifier.uri | https://doi.org/10.1007/s00417-018-4042-5 | - |
dc.description.abstract | Background: Macular contraction after anti-vascular endothelial growth factor (anti-VEGF) injections for diabetic macular edema (DME) was evaluated by documenting the displacement of macular capillary vessels and epiretinal membrane (ERM) formation. Methods: A total of 130 eyes were included in this retrospective study. The study group consisted of 63 eyes which had intravitreal anti-VEGF injections for DME, and the control group included 67 eyes without central DME. The study and the control groups were well balanced in terms of diabetes duration and HbA1c. The distances between the bifurcation of the macular capillary retinal vessels were measured, and ERM status was evaluated based on spectral-OCT findings on the initial and final visit. Results: In the study group, the mean number of injections was 4.7 ± 2.6 (3–14). The mean follow-up time was 16.7 ± 7.8 months in the study group whereas it was 20.7 ± 10.9 months in the control group (p = 0.132). The change in distance measurements between the reference points on macular capillary vessels was significant in all lines except line c (p < 0.05 for lines a, b, d, e, and f) in the study group whereas it was significant in only line e in the control group (p = 0.007, paired samples test). However, when the change in macular thickness was accounted as a confounding factor, the change in distances between the references points from the initial visit to the final visit lost its significance (repeated measures ANCOVA, p > 0.05). During follow-up, the number of cases with ERM changed from 10 to 12 in the study group whereas it remained three in the control group. Conclusion: There was a displacement of macular capillary vessels which was associated with the change in macular thickness in eyes having anti-VEGF injections for DME. The number of ERM cases did not change significantly during the follow-up. © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Verlag | en_US |
dc.relation.ispartof | Graefe's Archive for Clinical and Experimental Ophthalmology | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Anti-VEGF | en_US |
dc.subject | Diabetic macular edema | en_US |
dc.subject | Epiretinal membrane | en_US |
dc.subject | Macular contraction | en_US |
dc.subject | Macular vessel displacement | en_US |
dc.subject | Vitreoretinal interface | en_US |
dc.subject | aflibercept | en_US |
dc.subject | hemoglobin A1c | en_US |
dc.subject | ranibizumab | en_US |
dc.subject | angiogenesis inhibitor | en_US |
dc.subject | bevacizumab | en_US |
dc.subject | vasculotropin A | en_US |
dc.subject | adult | en_US |
dc.subject | Article | en_US |
dc.subject | best corrected visual acuity | en_US |
dc.subject | central macular thickness | en_US |
dc.subject | clinical article | en_US |
dc.subject | controlled study | en_US |
dc.subject | diabetic macular edema | en_US |
dc.subject | diabetic patient | en_US |
dc.subject | disease duration | en_US |
dc.subject | female | en_US |
dc.subject | follow up | en_US |
dc.subject | human | en_US |
dc.subject | intraocular pressure | en_US |
dc.subject | male | en_US |
dc.subject | middle aged | en_US |
dc.subject | priority journal | en_US |
dc.subject | quantitative diagnosis | en_US |
dc.subject | retina | en_US |
dc.subject | retina capillary | en_US |
dc.subject | retrospective study | en_US |
dc.subject | spectral domain optical coherence tomography | en_US |
dc.subject | vitreoretinal interface | en_US |
dc.subject | vitreous body | en_US |
dc.subject | antagonists and inhibitors | en_US |
dc.subject | complication | en_US |
dc.subject | diabetic retinopathy | en_US |
dc.subject | intravitreal drug administration | en_US |
dc.subject | macular edema | en_US |
dc.subject | optical coherence tomography | en_US |
dc.subject | pathology | en_US |
dc.subject | retina blood vessel | en_US |
dc.subject | retina macula lutea | en_US |
dc.subject | treatment outcome | en_US |
dc.subject | visual acuity | en_US |
dc.subject | Angiogenesis Inhibitors | en_US |
dc.subject | Bevacizumab | en_US |
dc.subject | Diabetic Retinopathy | en_US |
dc.subject | Female | en_US |
dc.subject | Follow-Up Studies | en_US |
dc.subject | Humans | en_US |
dc.subject | Intravitreal Injections | en_US |
dc.subject | Macula Lutea | en_US |
dc.subject | Macular Edema | en_US |
dc.subject | Male | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Ranibizumab | en_US |
dc.subject | Retinal Vessels | en_US |
dc.subject | Retrospective Studies | en_US |
dc.subject | Tomography, Optical Coherence | en_US |
dc.subject | Treatment Outcome | en_US |
dc.subject | Vascular Endothelial Growth Factor A | en_US |
dc.subject | Visual Acuity | en_US |
dc.subject | Vitreous Body | en_US |
dc.title | Quantitative assessment of macular contraction and vitreoretinal interface alterations in diabetic macular edema treated with intravitreal anti-VEGF injections | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 256 | en_US |
dc.identifier.issue | 10 | en_US |
dc.identifier.startpage | 1801 | |
dc.identifier.startpage | 1801 | en_US |
dc.identifier.endpage | 1806 | en_US |
dc.identifier.doi | 10.1007/s00417-018-4042-5 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 29922890 | en_US |
dc.identifier.scopus | 2-s2.0-85048761951 | en_US |
dc.identifier.wos | WOS:000444744500002 | en_US |
dc.identifier.scopusquality | Q1 | - |
dc.owner | Pamukkale University | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
3
checked on Dec 28, 2024
WEB OF SCIENCETM
Citations
2
checked on Dec 30, 2024
Page view(s)
46
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.